Performances and safety of a single proximal and distal (whole-leg) CUS for diagnosing DVT in outcome management studies
Reference . | Patients, No. . | Prevalence of all DVT, No. (%) . | Distribution of DVT level, No. (%) . | Three-month thromboembolic risk, % (95% CI)* . | |
---|---|---|---|---|---|
Proximal . | Distal . | ||||
Elias et al26 | 623 | 204 (33) | 112 (55) | 92 (45) | 0.5 (0.1-1.8) |
Schellong et al31 | 1 646 | 275 (17) | 121 (44) | 154 (56) | 0.3 (0.1-0.8) |
Stevens et al32 | 445 | 61 (14) | 42 (69) | 19 (31) | 0.8 (0.2-2.3) |
Subramaniam et al33 | 526 | 113 (22) | 49 (43) | 64 (57) | 0.2 (0.01-1.3) |
Bernardi et al11 | 1 053 | 278 (26) | 213 (76) | 65 (24) | 1.2 (0.5-2.2) |
Sevestre et al35 | 3 871 | 1 023 (26) | 454 (44) | 569 (56) | 0.6 (0.3-1.2) |
Sevestre et al34 | 1 926 | 395 (21) | 155 (39) | 240 (61) | 0.6 (0.1-1.7) |
Pooled estimate | 10 090 | 2 349 (23) | 1 146(49) | 1 203 (51) | 0.6 (0.3-0.9) |
Reference . | Patients, No. . | Prevalence of all DVT, No. (%) . | Distribution of DVT level, No. (%) . | Three-month thromboembolic risk, % (95% CI)* . | |
---|---|---|---|---|---|
Proximal . | Distal . | ||||
Elias et al26 | 623 | 204 (33) | 112 (55) | 92 (45) | 0.5 (0.1-1.8) |
Schellong et al31 | 1 646 | 275 (17) | 121 (44) | 154 (56) | 0.3 (0.1-0.8) |
Stevens et al32 | 445 | 61 (14) | 42 (69) | 19 (31) | 0.8 (0.2-2.3) |
Subramaniam et al33 | 526 | 113 (22) | 49 (43) | 64 (57) | 0.2 (0.01-1.3) |
Bernardi et al11 | 1 053 | 278 (26) | 213 (76) | 65 (24) | 1.2 (0.5-2.2) |
Sevestre et al35 | 3 871 | 1 023 (26) | 454 (44) | 569 (56) | 0.6 (0.3-1.2) |
Sevestre et al34 | 1 926 | 395 (21) | 155 (39) | 240 (61) | 0.6 (0.1-1.7) |
Pooled estimate | 10 090 | 2 349 (23) | 1 146(49) | 1 203 (51) | 0.6 (0.3-0.9) |
During 3-mo follow-up in patients left untreated after a normal complete (proximal and distal) CUS.